The NF-κB transcription factor in oncogenesis

Anticancer Research

Volumn 16, Issue 2, 1996, Pages 589-596

  Sharma, Harsh W ^a   Narayanan, Ramaswamy ^a  

^a HOFFMANN LA ROCHE INC   (United States)

Author keywords

Adhesion; Antisense; RelA; Transcription factor

Indexed keywords

CELL ADHESION MOLECULE; COMPLEMENTARY RNA; CYTOKINE; GROWTH FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHOSPHOROTHIOIC ACID; TRANSCRIPTION FACTOR; ANTISENSE OLIGONUCLEOTIDE; MESSENGER RNA;

ARTICLE; BINDING SITE; CARCINOGENESIS; CELL ADHESION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; TUMOR MODEL; ANIMAL; CELL DIVISION; CELL TRANSFORMATION; DRUG ANTAGONISM; GENETICS; HUMAN; METABOLISM; MOLECULAR GENETICS; NEOPLASM; NUCLEOTIDE SEQUENCE; NUDE MOUSE; PHYSIOLOGY; REVIEW;

ANIMALS; BASE SEQUENCE; BINDING SITES; CELL ADHESION; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; MICE; MICE, NUDE; MOLECULAR SEQUENCE DATA; NEOPLASMS; NF-KAPPA B; OLIGONUCLEOTIDES, ANTISENSE; PROMOTER REGIONS (GENETICS); RNA, MESSENGER; TRANSCRIPTION FACTORS;

EID: 0029666234     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (74)

1. Nabel G and Baltimore D: An inducible transcriptional factor activates expression of human immunodeficiency virus in T cells. Nature. 326: 711-713, 1987.
2. Lenardo M, Pierce JW and Baltimore D: Protein-binding sites in Ig gene enhancers determine transcriptional activity and inducibility. Science 236: 1573-1577, 1987.
3. Baeuerle PA and Baltimore D: The physiology of the NF-κB transcription factor. Mol Aspects Cell Regul 6: 409-432, 1991.
4. Nolan GP, Ghosh S, Liou HC, Tempst P and Baltimore D: DNA binding and IKB inhibition of the cloned p65 subunit of NF-κB, a rel-related polypeptide. Cell 64: 961-969, 1991.
5. Ruben SM, Dillon PJ, Schreck R, Henkel T, Chen CH, Maher M, Baeuerle PA, and Rosen CA: Isolation of a rel-related human cDNA that potentially encodes the 65-kD subunit of NF-κB. Science 251: 1490-1493, 1991.
6. Ghosh S, Gifford AM, Riviere LB, Tempst P, Nolan GP, and Baltimore D: Cloning of the p50 DNA binding subunit of NF-κB: Homology to rel and dorsal. Cell 62: 1019-1029, 1990.
7. Kieran M, Blank V, Logeat F, Vandekerchove J, Lottspeich F, LeBail O, Urban MB, Kourilsky P, Baeuerle PA, and Israel A: The DNA binding subunit of NF-κB is identical to factor KBF1 and homologous to the rel oncogene product. Cell 62: 1007-1018, 1990.
8. Bose HR,Jr.: The Rel family: Models for transcriptional regulation and oncogenic transformation. Biochim Biophys Acta 1114: 1-17, 1992.
9. Gilmore TD: Role of rel family genes in normal and malignant lymphoid cell growth. Cancer Surv 15: 69, 1992.
10. Rice, NR and Gilden, RV. The rel oncogene. In: The Oncogene Handbook, edited by Reddy, EP, Skalka, AM and Curran, T. New York: Elsevier, 1988, p. 495-512.
11. Steward R: Dorsal, an embryonic polarity gene in Drosophila is homologous to the vertebrate proto-oncogene, c-rel. Science 238: 692-694, 1987.
12. Grilli M, Chiu JS, and Lenardo MJ: NF-κB and Rel - participants in a multiform transcriptional regulatory system. Int Rev Cytol 143: 1-62, 1993.
13. Baeuerle PA and Henkel T: Function and activation of NF-κB in the immune system. Annu Rev Immunol 12: 141-179, 1994.
14. Stein CA and Cheng YC: Antisense oligonucleotides as therapeutic agents-Is the bullet Really Magical? Science 261: 1004-1012, 1993.
15. Stein CA and Narayanan R: Antisense oligonucleotides. Curr Opin Oncol 6: 587-594, 1994.
16. Higgins KA, Perez JR, Coleman TA, Dorshkind K, McComas WA, Sarmiento UM, Rosen CA, and Narayanan R: Antisense inhibition of dle p65 subunit of NF-κB blocks tumorigenicity and causes tumor regression. Proc Natl Acad Sci USA 90: 9901-9905, 1993.
17. McIntyre KW, Lombard-Gillooly K, Perez JR, Kunsch C, Sarmiento UM, Larigan JD, Landreth KT, and Narayanan R: A sense phosphorothioate oligonucleotide directed to the initiation codon of transcription factor NF-κB p65 causes sequence-specific immune stimulation. Antisense Res Dev 3: 309-322, 1993.
18. Narayanan R, Higgins KA, Perez JR, Coleman TA, and Rosen CA: Evidence for differential functions of the p50 and p65 subunits of NF-κB using a cell adhesion model. Mol Cell Biol 13: 3802-3810, 1993.
19. Sokoloski JA, Sartorelli AC, Rosen CA, and Narayanan R: Antisense oligonucleotides to the p65 subunit of NF-κB block CD1 1b expression and alter adhesion properties of differentiated HL-60 granulocytes. Blood 82: 625-632, 1993.
20. Perez JR, Li Y, Stein CA, Majumder S, van Oorschot A, and Narayanan R: Sequence independent induction of Sp-1 transcription factor by phosphorothioate oligodeoxynucleotides. Proc Natl Acad Sci USA 91: 5957-5961, 1994.
21. Perez JR, Higgins-Sochaski KA, Maltese JY, and Narayanan R: Regulation of adhesion and growth of fibrosarcoma cells by rel A NF-κB involves TGFβ. Mol Cell Biol 14: 5326-5332, 1994.
22. Narayanan R: Antisense therapy of cancer. In vivo 8: 787-794, 1994.
23. Kitajima I, Shinohara T, Bilakovics J, Brown DA, Xu X, and Nerenberg M: Ablation of transplanted HTLV-1 tax-transformed tumors in mice by antisense inhibition of NF-κB. Science 258: 1792-1795, 1992.
24. Mathew S, Murty VV, Dalla-Favera R, and Chaganti RS: Chromosomal localization of genes encoding the transcription factors, c-rel, NF-κBp50, NF-κBp65, and lyt-10 by fluorescence in situ hybridization. Oncogene 8: 191-193, 1993.
25. Gilmore TD and Morin PJ: The IκB proteins: Members of a multifunctional family. Trends Genet 9: 427433, 1993.
26. Ohno H, Takimoto G, and McKeithan TW: The candidate protooncogene bcl-3 is related to genes implicated in cell lineage determirlation and cell cycle control. Cell 60: 991-997, 1990.
27. Bours V, Franzoso G, Azarenko V, Park S, Kanno T, Brown K, and Siebenlist U: The oncoprotein Bcl-3 directly transactivates through κB motifs via association with DNA-binding p50B homodimers. Cell 72: 729-739, 1993.
28. Neri A, Chang CC, Lombardi L, Salina M, Corradini P, Maiolo AT, Chaganti RS, and Dalla-Favera R: B cell lymphoma-associated chromosomal translocation involves candidate oncogene lyl-10, homologous to NF-κB. a rel-related polypeptide. Cell 67: 1075-1087, 1991.
29. Narayanan R, Klement JF, Ruben SM, Higgins KA, and Rosen CA: Identification of a naturally occurring transforming variant of the p65 subunit of NF-κB. Science 256: 367-370, 1992.
30. Ruben SM, Narayanan R, Klement JF, Chen CH, and Rosen CA: Functional characterization of the NF-κB p65 transcriptional activator and an alternatively spliced derivative. Mol Cell Biol 12: 444-454, 1992.
31. Lyle R, Valleley EM, Sharpe PT, and Hewitt JE: An alternatively spliced transcript, p65delta2, of the gene encoding the p65 subunit of the transcription factor NF-κB. Gene 265-266, 1994.
32. Ruben S, Poteat H, and Tan TH: Cellular transcription factors and regulation of IL-2 receptor gene expression by HTLV-1 tax gene product. Science 241: 89-91, 1988.
33. Bours V, Dejardin E, Goujon-Letawe F, Merville MP, and Castronovo V: The NF-κB transcription factor and cancer: High expression of NFκB- and IκB-related proteins in tumor cell lines. Biochem Pharmacol 47: 145-149, 1994.
34. Hammarskjold ML and Simurda MC: Epstein-Barr virus latent membrane protein transactivates the human immunodeficiency virus type 1 long terminal repeat through induction of NF-κB activity. J Virol 66: 6496-6501, 1992.
35. Scala G, Quinto I, Ruocco MR, Mallardo M, Ambrosino C, Squitieri B, Tassone P, and Venuta S: Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1. J Virol 67: 2853-2861, 1993.
36. Maltese JY, Vassilev L, Sharma HW, and Narayanan R: Sequence context of antisense relA/NF-κB phosphorothioates determines specificity. Nucleic Acids Res 7: 1146-1151, 1995.
37. Sharma HW, Perez JR, Higgins-Sochaski KA, Hsaio R, and Narayanan R: A transcription factor decoy approach to decipher the role of NF-κB in oncogenesis. Anticancer Res 16: 61-70, 1996.
38. Lawlor K and Narayanan R: Persistent expression of the twnor suppressor gene DCC is essential for neuronal differentiation. Cell Growth Different 3: 609-616, 1992.
39. Albelda SM and Buck CA: Integrins and other cell adhesion molecules. FASEB J 4: 2868-2880, 1990.
40. Hynes RO: Integrins: Versatility, modulation, and signaling in cell adhesion. Cell 69: 11-25, 1992.
41. Hynes RO: The impact of molecular biology on models for cell adhesion. BioEssays 16: 663-669, 1994.
42. Baeuerle PA and Baltimore D: Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NF-κB transcription factor. Cell 53: 211-217, 1988.
43. Urban MB and Baeuerle PA: The 65-kD subunit of NF-κB is a receptor for IκB and a modulator of DNA-binding specificity. Genes Dev 4: 1975-1984, 1990.
44. Kunsch C, Ruben SM, and Rosen CA: Selection of optimal κB/Rel DNA binding motifs: Interaction of both subunits of NF-κB with DNA is required for transcriptional activation. Mol Cell Biol 12: 4412-4421, 1992.
45. Parry GC and Mackman N: A set of inducible genes expressed by activated human monocytic and endothelial cells contain κB-like sites that specifically bind c-Rel-p65 heterodimers. J Biol Chem 269: 20823-20825, 1994.
46. Himes SR, Coles LS, Katsikeros R, Lang RK, and Shannon MF: HTLV-1 tax activation of the GM-CSF and G-CSF promoters requires the interaction of NF-κB with other transcription factor families. Oncogene 8: 3189-3197, 1993.
47. Dunn SM, Coles LS, Lang RK, Gerondakis S, Vadas MA, and Shannon MF: Requirement for nuclear factor (NF)-κB p65 and NF-interleukin-6 binding elements in the tumor necrosis factor response region of the granulocyte colony-stimulating factor promoter. Blood 83: 2469-2479, 1994.
48. Sharma HW, Higgins-Sochaski KA, Perez JR, and Narayanan R: A DNA motif present in αV integrin promoter exhibits dual binding preference to distinct transcription factors. Anticancer Res 15: 1857-1868, 1995.
49. Goldring CE, Narayanan R, Lagadec P, and Jeannin JF: Transcriptional inhibition of the inducible nitric oxide synthase gene by competitive binding of NF-κB/Rel proteins. Biochem Biophys Res Commun 209: 73-79, 1995.
50. Eck SL, Perkins ND, Carr DP, and Nabel GJ: Inhibition of phorbol ester-induced cellular adhesion by competitive binding of NF-κB in vivo. Mol Cell Biol 13: 6530-6536, 1993.
51. Sarmiento U, Perez JR, Becker JM, and Narayanan R: In vivo toxicologic effects of rel A antisense phosphorothioates in CD-1 mice. Antisense Res Dev 4: 99-107, 1994.
52. Manning, AM and Anderson, DC. Transcription factor NF-κB: An emerging regulator of inflammation. In: Annual Reports in Medicinal Chemistry-29, edited by Lee, JC. Academic Press, Inc., 1994, p. 235-244,
53. Sha WC, Liou HC, Tuomanen EI, and Baltimore D: Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses. Cell 80: 321-330, 1995.
54. Weih F, Carrasco D, Durham SK, Barton DS, Rizzo CA, Ryseck RP, Lira SA, and Bravo R: Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-κB/Rel family. Cell 80: 331-340, 1995.
55. Beg AA, Sha WC, Bronson RT, Ghosh S, and Baltimore D: Embryonic lethality and liver degeneration in mice lacking the relA component of NF-kappa B. Nature 376: 167-170, 1995.
56. Menon SD, Qin S, Guy GR, and Tan YH: Differential Induction of Nuclear NF-κB by protein phosphatase inhibitors in primary and transformed human cells. J Biol Chem 268: 26806-26812, 1993.
57. Kopp E and Ghosh S: Inhibition of NF-κB by sodium salicylate and aspirin. Science 265: 956-959, 1994.
58. Sen R and Baltimore D: Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 46: 705-716, 1986.
59. Sen R and Baltimore D: Inducibility of k immunoglobulin enhancer-binding protein NF-κB by a post-translational mechanism. Cell 47: 921-928, 1986.
60. Baldwin AS,Jr., LeClair KP, Singh H, and Sharp PA: A large protein containing zinc finger domains binds to related sequence elements in the enhancers of the class I major histocompatibility complex and kappa immunoglobulin genes. Mol Cell Biol 10: 1406-1414, 1990.
61. Liou HC and Baltimore D: Regulation of the NF-κB/rel transcription factor and IKB inhibitor system. Curr Opin Cell Biol 5: 477-487, 1993.
62. Miyamoto S, Schmitt MJ, and Verma IM: Qualitative changes in the subunit composition of KB-binding complexes during murine B-cell differentiation. Proc Natl Acad Sci USA 91: 5056-5060, 1994.
63. Sun SC, Ganchi PA, Ballard DW, and Greene WC: NF-κB controls expression of inhibitor IκBα: Evidence for an Inducible Autoregulatory Pathway. Science 259: 1912-1915, 1993.
64. Sun SC, Ganchi PA, Beraud C, Ballard DW, and Greene WC: Autoregulation of the NF-κB transactivator RelA (p65) by multiple cytoplasmic inhibitors containing anlyrin motifs. Proc Natl Acad Sci USA 91: 1346-1350, 1994.
65. Shirakawa F and Mizel SB: In vitro activation and nuclear translocation of NF-κB catalyzed by cyclic AMP-dependent protein kinase and protein kinase C. Mol Cell Biol 9: 2424-2430, 1989.
66. Palombella VJ, Rando OJ, Goldberg AL, and Maniatis T: The ubiquitin-proteasome pathway is required for processing the NFKB1 precursor protein and the activation of NF-κB. Cell 78: 773-785, 1994.
67. Henkel T, Machleidt T, Alkalay I, Kranke M, Ben-Neriah Y, and Baeuerle PA: Rapid proteolysis of IκB-α is necessary for activation of transcription factor NF-κB. Nature 365: 182-185, 1993.
68. Beauparlant P, Kwan I, Bitar R, Chou P, Koromilas AE, Sonenberg N, and Hiscott J: Disruption of IKBα regulation by antisense RNA expression leads to malignant transformation. Oncogene 9: 3189-3197, 1994.
69. Ueberla K, Lu Y, Chung E, and Haseltine WA: The NF-κB p65 promoter. J Acquir Immune Defic Syndr 6: 227-230, 1993.
70. Stein B and Baldwin AS, Jr.: Distinct mechanisms for regulation of the interleukin-8 gene involve synergism and cooperativity between C/EBP and NF-κB. Mol Cell Biol 13: 7191-7198, 1993.
71. Kerr LD, Ransone U, Wamsley P, Schmitt MJ, Boyer TG, Zhou Q, Bork AJ, and Verma IM: Association between proto-oncoprotein Rel and TATA-binding protein mediates transcriptional activation by NF-κB. Nature 365: 412-419, 1993.
72. Perkins ND, Edwards NL, Duckett CS, Agranoff AB, Schmid RM, and Nabel GJ: A cooperative interaction between NF-κB and Spl is required for HIV-I enhancer activation. EMBO J 12: 3551-3558, 1993.
73. Stein B, Herrlich P, Greene WC, and Baldwin AS: Functional and physical associations of NF-κB with members of the C/EBP and AP-1 families of transcription factors: A Rel domain/BZIP interaction. J Cell Biochem (Supp) 17A: 149, 1993.
74. Xu X, Prorock C, Ishikawa H, Maldonado E, Ito Y, and Gelinas C: Functional interaction of the v-Rel and c-Rel oncoproteins with the TATA-binding protein and association with transcription factor IIB. Mol Cell Biol 13: 6733-6741, 1993.